Eco Animal Health Group PLC (LON:EAH) had its stock rating reiterated as ‘Buy’ in a report released by analysts at N+1 Singer.
N+1 Singer today set a target price of 498 on the company’s stock. According to the analyst this now indicates there is a potential decrease of -2.35% from Eco Animal Health Group PLC’s current price of 510.
Over the last twelve months Eco Animal Health Group PLC’s stock price has increased by 76.98% from 288.17 to 510.
There are currently 63,538,000 shares in issue with a current share value of 510 giving Eco Animal Health Group PLC a market capitalisation of 324.04M GBp .
Eco Animal Health Group PLC (LON:EAH) has a 50 day moving average of 472.16 and a 200 day moving average of 417.89. The 52 week high for the share price is 525 while the 52 week low for the stock is 271.6.
Eco Animal Health Group plc is engaged in the development, registration and marketing of pharmaceutical products for global animal health markets. The Company’s principal activity is the manufacture and supply of animal health products across the globe. These activities are conducted on a global scale, through a network, including both regional offices (notably in Shanghai and Princeton) and overseas subsidiaries. The Company’s products include Aivlosin and Ecomectin. Aivlosin is an antibiotic that treats a range of specific enteric (gut) and respiratory diseases in pigs and poultry. Ecomectin is an endectocide that controls worms, ticks, lice and mange in grazing stock and pigs. It operates in the United Kingdom and Europe, the Far East, Latin America, North America, and the Middle East and Africa. Its subsidiaries include Eco Animal Health Limited and ECO Animal Health do Brasil Comercio de Produtos Veterinarios Ltda.